Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 2Phase 2 2Phase 3 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Breast Neoplasms 45Prostatic Neoplasms 41Brain Neoplasms 27Lung Neoplasms 19Glioblastoma 17Glioma 16Neoplasms 13Neoplasm Metastasis 13Carcinoma, Non-Small-Cell Lung 13Head and Neck Neoplasms 10Pancreatic Neoplasms 8Central Nervous System Neoplasms 8Uterine Cervical Neoplasms 7Lymphoma 7Carcinoma, Hepatocellular 7Rectal Neoplasms 6Oligodendroglioma 6Gliosarcoma 6Carcinoma, Squamous Cell 6Astrocytoma 6Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ependymoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Intraductal, Noninfiltrating 5Sarcoma 4Meningioma 4Colonic Neoplasms 4Breast Neoplasms, Male 4

Interventions

Peripheral Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Cyclosporine 5fludarabine phosphate 4Melphalan 4Mycophenolic Acid 3Methotrexate 3Etoposide 3Cytarabine 3Cyclophosphamide 3Carmustine 3Busulfan 3Antilymphocyte Serum 3Vincristine 2Thiotepa 2Prednisone 2Magnetic Resonance Spectroscopy 2Leucovorin 2Doxorubicin 2Carboplatin 2thymoglobulin 1plerixafor 1etoposide phosphate 1denileukin diftitox 1amuvatinib 1Vindesine 1Vinblastine 1Triamcinolone Acetonide 1Therapeutics 1Salvia hispanica seed extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large-Cell, Anaplastic × Magnetic Resonance Spectroscopy × Clear all
NCT00504205 2013-08-02

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00110006 2010-06-11

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Case Comprehensive Cancer Center

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡